Recombinant Human GPT Protein，His

Research on GPT (glutamate pyruvate transaminase) recombinant proteins has gained significant attention due to their crucial role in metabolic pathways and potential therapeutic applications. GPT, an enzyme primarily found in the liver and kidneys, catalyzes the reversible transfer of amino groups between glutamate and pyruvate, leading to the production of α-ketoglutarate and alanine. This reaction is vital for amino acid metabolism and energy homeostasis. The recombinant production of GPT proteins allows for detailed biochemical studies, facilitating the exploration of their structure-function relationships and enzymatic mechanisms. Moreover, the ability to produce these proteins in a controlled manner enables researchers to investigate their roles in various diseases, particularly metabolic disorders and liver dysfunctions. As the understanding of GPT's involvement in pathological conditions grows, there is increasing interest in leveraging recombinant GPT proteins for diagnostic and therapeutic strategies. This includes the potential development of novel drugs targeting metabolic pathways influenced by GPT activity, as well as the use of GPT as a biomarker for assessing liver function. The advancement of genetic engineering and protein expression systems has further propelled research into GPT recombinant proteins, making them invaluable tools in both basic and applied biomedical research.